- Home
- YMM vs QGEN Comparison
YMM vs QGEN Comparison
Compare YMM & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | YMM | QGEN |
|---|---|---|
| Founded | 2011 | 1986 |
| Country | China | Netherlands |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 10.2B |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | YMM | QGEN |
|---|---|---|
| Price | $9.96 | $54.06 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $12.00 | ★ $48.84 |
| AVG Volume (30 Days) | ★ 11.1M | 2.5M |
| Earning Date | 03-04-2026 | 02-04-2026 |
| Dividend Yield | 1.93% | ★ 4.44% |
| EPS Growth | 29.34 | ★ 331.25 |
| EPS | 0.53 | ★ 1.94 |
| Revenue | $1,751,813,549.00 | ★ $2,070,781,000.00 |
| Revenue This Year | $11.40 | $7.12 |
| Revenue Next Year | $7.83 | $5.95 |
| P/E Ratio | ★ $18.99 | $28.03 |
| Revenue Growth | ★ 19.09 | 5.32 |
| 52 Week Low | $9.45 | $39.61 |
| 52 Week High | $14.07 | $57.82 |
Technical Indicators
Market Signals| Indicator | YMM | QGEN |
|---|---|---|
| Relative Strength Index (RSI) | 34.44 | 71.70 |
| Support Level | $9.76 | $46.07 |
| Resistance Level | $10.24 | $57.82 |
| Average True Range (ATR) | 0.45 | 1.99 |
| MACD | -0.06 | 0.89 |
| Stochastic Oscillator | 17.07 | 71.16 |
Price Performance
Historical ComparisonAbout YMM Full Truck Alliance Co. Ltd. (each representing 20)
Full Truck Alliance Co Ltd, through its subsidiaries, provides comprehensive services for shippers and truckers through its mobile and website platforms. Its principal operations are in the People's Republic of China. The group derives its revenues principally from shippers and trucker's use of its platforms in connection with freight matching services and value-added services.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).